SMSMED: Guidance cut amid tariff and currency risks, but US presence and cost controls support resilience

About this update from Scandinavian Medical Solutions A/s

Revenue and EBITDA guidance were significantly lowered due to geopolitical risks, tariff uncertainty, and a weaker US dollar. Order book visibility has shortened, but strong US presence and cost controls provide strategic flexibility. Demand for used equipment remains robust, especially in private US healthcare.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Scandinavian Medical Solutions A/s